Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Leukemias

Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia

Abstract

Mercaptopurine has been used in continuing treatment of childhood acute lymphoblastic leukaemia since the mid 1950s. Recent advances in the understanding of thiopurine pharmacology indicated that thioguanine (TG) might be more effective than mercaptopurine (MP). The US and UK cooperative groups began randomised thiopurine trials and agreed prospectively to a meta-analysis. All randomised trials of TG versus MP were sought, and data on individual patients were analysed by standard methods. Combining three trials (from US, UK and Germany), the overall event-free survival (EFS) was not significantly improved with TG (odds ratio (OR)=0.89; 95% confidence interval 0.78–1.03). Apparent differences in results between trials may be partly explained by the different types of patients studied. The larger treatment effect reported in males in the US trial was confirmed in the other trials. There was heterogeneity between sex/age subgroups (P=0.001), with significant EFS benefit of TG only observed for males aged <10 years old (OR=0.70; 0.58–0.84), although this did not result in a significant difference in overall survival (OR=0.83; 0.62–1.10). Additional toxicity occurs with TG. Mercaptopurine remains the standard thiopurine of choice, but further study of TG may be warranted to determine whether it could benefit particular subgroups.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Harms DO, Gobel U, Spaar HJ, Graubner UB, Jorch N, Gutjahr P et al. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood 2003; 102: 2736–2740.

    Article  CAS  Google Scholar 

  2. Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J et al. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 2006; 368: 1339–1348.

    Article  CAS  Google Scholar 

  3. Stork LC, Sather H, Hutchinson HJ, Broxson EH, Matloub Y, Yanofsky R et al. Comparison of mercaptopurine (MP) with thioguanine (TG) and IT methotrexate (ITM) with IT ‘Triples’ (ITT) in children with SR-ALL: results of CCG-1952. Blood 2002; 100: 156a, A585.

    Google Scholar 

  4. Stork LC, Matloub Y, Broxson E, La M, Yanofsky R, Sather H et al. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. Blood 2010; 115: 2740–2748.

    Article  CAS  Google Scholar 

  5. Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG). Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis. Br J Haematol 2009; 145: 376–388.

    Article  Google Scholar 

  6. Higgins JP, Thompson SG, Deeks JJ, Altman DG . Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.

    Article  Google Scholar 

  7. Lennard L, Lilleyman JS . Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol 1989; 7: 1816–1823.

    Article  CAS  Google Scholar 

  8. Lilleyman JS, Lennard L, Rees CA, Morgan G, Maddocks JL . Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization. Br J Cancer 1984; 49: 703–707.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The work was funded by a grant from the Kay Kendall Leukaemia Fund (KKL293) with additional support from the Cancer Research UK and Medical Research Council. The secretariat for this work was at CTSU, Oxford University (T Elphinstone, V Evans, L Gettins, C Hicks, L MacKinnon, P Morris, S Richards, R Wade, C Wise).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to S Richards.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Escherich, G., Richards, S., Stork, L. et al. Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia. Leukemia 25, 953–959 (2011). https://doi.org/10.1038/leu.2011.37

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.37

Keywords

This article is cited by

Search

Quick links